From the Sector

Reset
4 results
05.05.2021

Lenzing Group with an excellent start into 2021

Lenzing – The Lenzing Group had a clearly positive revenue and earnings development in the first quarter of 2021. Growing optimism in the textile and apparel industry as a result of the vaccination progress and the continuing recovery in retail led to a significant increase in demand and higher prices in the global fiber market.

•    Significant increase in operating result: EBITDA at EUR 94.5 mn, cash flow from operating activities more than tripled
•    Major strategic projects continue fully on track – production start of the lyocell plant in Thailand expected in the fourth quarter 2021
•    Upper Austria’s largest photovoltaic plant at the Lenzing site
•    Lenzing exits Hygiene Austria joint venture
•    Guidance 2021: Lenzing expects operating result at least at pre-crisis level

Please read the attached document for more information.

Lenzing – The Lenzing Group had a clearly positive revenue and earnings development in the first quarter of 2021. Growing optimism in the textile and apparel industry as a result of the vaccination progress and the continuing recovery in retail led to a significant increase in demand and higher prices in the global fiber market.

•    Significant increase in operating result: EBITDA at EUR 94.5 mn, cash flow from operating activities more than tripled
•    Major strategic projects continue fully on track – production start of the lyocell plant in Thailand expected in the fourth quarter 2021
•    Upper Austria’s largest photovoltaic plant at the Lenzing site
•    Lenzing exits Hygiene Austria joint venture
•    Guidance 2021: Lenzing expects operating result at least at pre-crisis level

Please read the attached document for more information.

Source:

Lenzing Aktiengesellschaft

Lenzing reports improved results in the third quarter and remains strategically on course (c) Lenzing
Lenzing reports improved results in the third quarter and remains strategically on course
04.11.2020

Lenzing reports improved results in the third quarter and remains strategically on course

  • Significant improvement in the third quarter after COVID-19-related slump on the fiber market
  • Measures for structural earnings improvement with positive impact
  • Strategic investment projects remain on track
  • Hygiene Austria joint venture: Successful growth and continued focus on certified protective masks
  • Lenzing wins the Austrian State Prize for Innovation with LENZING™ Web Technology

Lenzing – In the first three quarters of 2020, the Lenzing Group successfully responded to the extremely difficult market environment of increased pressure on prices and volume due to the COVID-19 crisis by implementing a broad package of measures and remains fully on track in terms of its strategy. The cooperation with partners along the value chains was intensified and Lenzing was agile and flexible in adjusting production volume to demand.

  • Significant improvement in the third quarter after COVID-19-related slump on the fiber market
  • Measures for structural earnings improvement with positive impact
  • Strategic investment projects remain on track
  • Hygiene Austria joint venture: Successful growth and continued focus on certified protective masks
  • Lenzing wins the Austrian State Prize for Innovation with LENZING™ Web Technology

Lenzing – In the first three quarters of 2020, the Lenzing Group successfully responded to the extremely difficult market environment of increased pressure on prices and volume due to the COVID-19 crisis by implementing a broad package of measures and remains fully on track in terms of its strategy. The cooperation with partners along the value chains was intensified and Lenzing was agile and flexible in adjusting production volume to demand. In addition, Lenzing also intensified measures for structural earnings improvement to mitigate the effect of the pressure on fiber prices and demand for fibers, and reduced its operating costs significantly as a result.

Please read the attached document for more information

Source:

Lenzing Aktiengesellschaft

Lenzing Aktiengesellschaft (c) Lenzing Aktiengesellschaft
Lenzing Aktiengesellschaft
05.08.2020

COVID-19 impacts revenue and earnings of the Lenzing Group in the first half of 2020

  • Fiber prices and demand under pressure
  • Measures to protect employees, customers and suppliers and to keep plants operational implemented successfully
  • Joint venture Hygiene Austria established for industrial production of protective masks in the fight against the COVID-19 pandemic – new distribution channel via shop.hygiene-austria.at
  • Strategic investment projects progress according to plan – financing agreements for construction of pulp plant in Brazil concluded as planned
  • Revenue and operating result in the remaining quarters of 2020 expected to exceed that of the second quarter

Lenzing – In the first half of 2020, the Lenzing Group faced a historically difficult market environment with increased pressure on prices and volumes resulting from the COVID-19 crisis. To counteract that, Lenzing intensified its cooperation with partners along the value chains and adjusted its production volumes and sales prices to market reality.

  • Fiber prices and demand under pressure
  • Measures to protect employees, customers and suppliers and to keep plants operational implemented successfully
  • Joint venture Hygiene Austria established for industrial production of protective masks in the fight against the COVID-19 pandemic – new distribution channel via shop.hygiene-austria.at
  • Strategic investment projects progress according to plan – financing agreements for construction of pulp plant in Brazil concluded as planned
  • Revenue and operating result in the remaining quarters of 2020 expected to exceed that of the second quarter

Lenzing – In the first half of 2020, the Lenzing Group faced a historically difficult market environment with increased pressure on prices and volumes resulting from the COVID-19 crisis. To counteract that, Lenzing intensified its cooperation with partners along the value chains and adjusted its production volumes and sales prices to market reality. The disciplined implementation of the sCore TEN corporate strategy and the focus on specialty fibers continued to have a positive impact.*

*Please read the attached document for more information

More information:
Lenzing AG Covid-19 Coronakrise
Source:

Lenzing Aktiengesellschaft

18.06.2020

CHT is implementing antiviral textile treatment in the textile industry

  • HeiQ Viroblock by CHT provides effective antiviral treatment on different fabrics
  • No infective viruses left after 30 minutes
  • For a wide range of protective textile applications

CHT is cooperating with HeiQ by implementing the HeiQ Viroblock by CHT in the textile industry, globally. HeiQ Viroblock by CHT is among the first textile technologies in the world to be proven effective against SARS-CoV-2 in the laboratory.

HeiQ Viroblock by CHT is a textile treatment for industrial use, designed to provide textiles with antiviral and antibacterial properties. The combination of silver antimicrobial technology and vesicle technology rapidly destroy enveloped viruses including coronaviruses. It has previously been tested against coronavirus 229E, another strain of virus in the Coronavirus family.

  • HeiQ Viroblock by CHT provides effective antiviral treatment on different fabrics
  • No infective viruses left after 30 minutes
  • For a wide range of protective textile applications

CHT is cooperating with HeiQ by implementing the HeiQ Viroblock by CHT in the textile industry, globally. HeiQ Viroblock by CHT is among the first textile technologies in the world to be proven effective against SARS-CoV-2 in the laboratory.

HeiQ Viroblock by CHT is a textile treatment for industrial use, designed to provide textiles with antiviral and antibacterial properties. The combination of silver antimicrobial technology and vesicle technology rapidly destroy enveloped viruses including coronaviruses. It has previously been tested against coronavirus 229E, another strain of virus in the Coronavirus family.

The latest testing with SARS-CoV-2 virus was conducted by researchers at the Doherty Institute, a joint venture between the University of Melbourne and The Royal Melbourne Hospital, an internationally renowned institution combining research, teaching, public health and reference laboratory services, diagnostic services and clinical care into infectious diseases and immunity. The research project involved a disinfection test protocol that simulated the real-life interaction of small aerosol droplets contaminating clothing. A known concentration of SARS-CoV-2 virus was contacted with the sample fabric for 30 minutes followed by measurement of remaining infectious SARS-CoV-2 viruses. The fabric sample treated with HeiQ Viroblock by CHT had no infective viruses left after 30 minutes. The result indicated a SARS-CoV-2 virus reduction of 99.99% relative to the inoculum control.

More information:
CHT Germany GmbH CHT Germany
Source:

CHT Germany GmbH